Skip to main content
Day.News — Local News. Real Community.
COLUMBUS DAY NEWS
Local News. Real Community.
health
2 min read

Medicare Advantage insurers denied long-term care authorizations at high rates, HHS inspector general reports

The Department of Health and Human Services inspector general found that three major Medicare Advantage insurers denied prior authorization requests for long-term care services at rates exceeding those of competitors. The report examined denial patterns across multiple plans.

06/15/2026 · South Dakota edition

Advertisement

Advertisement

Why it matters locally: South Dakota has an aging population with higher-than-average Medicare Advantage enrollment; residents relying on these plans for long-term care services may face increased denials and delays in accessing nursing home and home health benefits.

The Department of Health and Human Services inspector general documented that three major Medicare Advantage insurers denied prior authorization requests for long-term care services at unusually high rates, according to a report released this week. UnitedHealthcare, CVS Health and Humana each showed denial rates that outpaced other carriers reviewed in the federal examination. The inspector general's office did not disclose the specific denial percentages for each insurer in its preliminary findings. Medicare Advantage plans require insurers to approve coverage for certain medical services before patients receive them through the prior authorization process. Long-term care services, which include nursing home and home health assistance for extended periods, represent a significant category of coverage requests. The report focused on how often insurers rejected these authorization requests compared to approval rates at other Medicare Advantage plans. Denials prevent beneficiaries from accessing covered services unless they challenge the decision through an appeals process. The inspector general's office did not announce enforcement actions or penalties against the three insurers at the time of the report's release. The examination came as federal regulators have increased scrutiny of Medicare Advantage denial practices in recent years, citing concerns about whether plans properly approve medically necessary services. Medicare Advantage plans, which serve more than 28 million beneficiaries, operate as an alternative to traditional Medicare. These private plans contract with the federal government to provide coverage and must follow federal rules governing medical necessity determinations and authorization timelines. The report added to existing concerns about prior authorization delays and denials in the Medicare Advantage program. Patient advocacy groups and medical associations have stated that extensive authorization requirements can delay care and burden healthcare providers with administrative tasks. UnitedHealthcare operates as a division of UnitedHealth Group, one of the nation's largest health insurance companies. CVS Health operates Aetna, which offers Medicare Advantage plans. Humana ranks among the largest standalone Medicare Advantage insurers by enrollment. The inspector general's office indicated it would continue monitoring denial patterns across Medicare Advantage plans. The agency did not specify whether it would conduct additional reviews of the three insurers or expand its examination to other plans.

Related Topics

Editorial Transparency
AI-Generated · Written by National Desk

Article Ratings

Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0

How do you feel about this story?

NA

National Desk

Trust 3.1104047 articles8,231,170 views75% fact accuracy
View Profile

Sign in to follow this author from their profile.

Discussion (0)

Join the Conversation

Join the conversation

Sign in to share your thoughts, reply to readers, and like comments.

Sign in to comment
Sort by:
0 comments

No comments yet. Be the first to comment!

Trending Now

Trending stories will appear here.

More from South Dakota

No other local stories are available right now.

Events & Things to Do

Read section →

Upcoming events will appear here.

Advertisement

Advertisement

Keep Reading

Related Stories

More health stories from South Dakota

health

Family Calls for Allergy Management Ratings After Child's Death

The family of Mia St Hilaire, a 12-year-old who died after an anaphylactic reaction, now advocates for improved allergy management ratings. Mia consumed a milkshake that triggered her tree nut allergy.

Read Story →
health

FDA to Conclude Abortion Pill Safety Review by March

The Food and Drug Administration (FDA) will finalize its safety review of mifepristone in March. A Louisiana federal judge mandated this update as part of a legal challenge seeking to reverse a policy allowing mail delivery of the abortion medication.

Read Story →
health

GLP-1 Medications Show Potential in Addressing Addiction

New evidence suggests GLP-1 drugs, commonly used for diabetes and weight loss, may also reduce cravings for addictive substances. Scientists are conducting studies to determine if these medications can help individuals with substance use disorders. This research explores a potential new application for GLP-1s in public health.

Read Story →
health

Report Examines Impact of Trump Administration's Drug Pricing Initiatives

A recent report evaluated the Trump administration's claims regarding drug prices, including the effectiveness of TrumpRx discounts. Findings indicate a mixed impact on prescription drug costs for consumers. The administration has asserted that the U.S. now pays the world's lowest drug prices.

Read Story →
health

Cost of GLP-1 Medications Prompts Search for Alternatives

Many Americans face financial hurdles when trying to access GLP-1 medications. These cost barriers have prompted some patients to seek out alternative, unregulated versions. The situation highlights ongoing challenges in prescription drug affordability.

Read Story →
health

Experimental Vaccine Shows Promise Against Glioblastoma

An experimental vaccine for glioblastoma, a severe form of brain cancer, demonstrates potential to prolong life for patients. Developers report encouraging results from ongoing studies.

Read Story →
Scroll for more stories